Proteomics is a large-scale study of proteins, particularly their structures and functions. Proteins are vital parts of living organisms as they are the main components of the physiological metabolic pathways of cells. There is an urgent need in the life science industry for technologies and products that can analyze and study the human proteome in a high-throughput, multiplex, and low-cost manner. Proteomic technologies are evolving to meet more of these needs, so it is important to keep abreast of these dynamics.
The proteomics industry is extremely diverse, with intense competition in many market segments. The industry contains a range of lifecycle technologies, which make it attractive to companies that can innovate in early or emerging market segments. Increased demand for personalized medicines and increased R&D activities in proteomics are the major driving factors for the growth of this market. However, the market is constrained by limited funding from the government in proteomics research and development.
In this report, the market is segmented by instrumentation technology, services market, application, and geography. Instrumentation technology is further segmented into protein microarray, spectroscopy, and chromatography. The services segment is segmented into analytical laboratory services and data analysis & maintenance. The proteomics application is segmented into drug discovery, clinical diagnosis, and others. In the country level analysis, the market is segmented into the U.S., Canada, and Mexico. The U.S. holds the majority of the market share, which accounts for more than 60.0% of the market and is valued at USD 2.68 billion, followed by Canada and Mexico.
In the U.S.A., protein microarray is the major segment dominating the market, accounting for almost half of the market. Microarray technology allows the simultaneous analysis of thousands of parameters within a single experiment. Spectroscopy occupies the second place after protein microarray in the proteomics market, holding 30.0% of the market share accounting for USD 1.37 billion in 2014. The two key proteomic technologies, mass spectrometry, and biochips, are benefiting from the large-scale genomic and proteomic initiatives.
Market analysis for the North American proteomics market, with region-specific assessments and competition analysis on the global and regional scale.
Market definition along with the identification of key drivers and restraints.
Identification of factors instrumental in changing the market scenario, rising prospective opportunities, and identification of key companies that can influence this market on a global and regional scale.
Extensively researched competitive landscape section with profiles of major companies along with their market share.
Identification and analysis of the macro and micro factors that affect the North American proteomics market.
A comprehensive list of key market players along with the analysis of their current strategic interests and key financial information.
A wide-ranging knowledge and insights about the major players in this industry and the key strategies adopted by them to sustain and grow in the studied market
Insights on the major countries in which this industry is blooming and to also identify the regions that are still untapped.
1.1 Market Definition
1.2 Market Size Estimation
2. EXECUTIVE SUMMARY
3. MARKET OVERVIEW
3.2 Market Drivers
3.3 Market Restraints
3.4 Market Opportunities
4. Global Proteomics Market- Segmentation
4.1 By Instrumentation Technology
4.1.1 Protein Microarray
4.1.3 X-Ray Crystallography
4.2 By Services Market
4.2.1 Analytical Laboratory Services
4.2.2 Data Analysis & Maintenance
4.3 By Applications
4.3.2 Drug Discovery
4.3.3 Clinical Diagnosis
4.4 By Geography
4.4.1 North America
5. Competitive Analysis
5.1 Mergers & Acquisitions
5.2 New Product Launches
5.3 Agreements & Collaborations
5.5 Other Developments
6. Company Profiles
6.1 Thermo Fisher Scientific Inc.
6.2 Danaher Corporation
6.3 Bio-Rad Laboratories, Inc.
6.4 Affymetrix Inc.
6.5 Sigma-Aldrich Corp
6.6 GE Healthcare
6.7 Agilent technologies